25-Feb-2026
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC)
TipRanks (Wed, 25-Feb 10:06 AM ET)
TipRanks (Wed, 25-Feb 10:00 AM ET)
Wells Fargo Reaffirms Their Hold Rating on Henry Schein (HSIC)
TipRanks (Wed, 25-Feb 7:29 AM ET)
Henry Schein: Solid Growth but Margin Pressures and Valuation Drive Sell Rating
TipRanks (Wed, 25-Feb 6:46 AM ET)
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC)
TipRanks (Wed, 25-Feb 4:59 AM ET)
Henry Schein Balances Strong Growth With Margin Pressure
TipRanks (Tue, 24-Feb 7:06 PM ET)
Seeking Alpha News (Tue, 24-Feb 3:28 PM ET)
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC)
TipRanks (Tue, 24-Feb 3:10 PM ET)
Analysts Conflicted on These Healthcare Names: Elanco Animal Health (ELAN) and Henry Schein (HSIC)
TipRanks (Tue, 24-Feb 3:00 PM ET)
Henry Schein Stock Hits 52-Week High - Here's Why
Benzinga (Tue, 24-Feb 1:55 PM ET)
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of February 25, 2026, HSIC stock price declined to $81.91 with 2,248,874 million shares trading.
HSIC has a beta of 0.27, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.04 to the broad based SPY ETF.
HSIC has a market cap of $10.24 billion. This is considered a Large Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.04.
In the last 3 years, HSIC traded as high as $89.29 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VOO, RSP, VB, VBR.
HSIC has underperformed the market in the last year with a return of +5.5%, while SPY returned +17.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HSIC shares. However, HSIC has outperformed the market in the last 3 month and 2 week periods, returning +10.0% and +1.1%, while SPY returned +3.9% and +0.1%, respectively. This indicates HSIC has been having a stronger performance recently.
HSIC support price is $81.68 and resistance is $85.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC shares will trade within this expected range on the day.